LAB icon

Standard BioTools
LAB

Overview Fund Activity

144 hedge funds and large institutions have $480M invested in Standard BioTools in 2024 Q2 according to their latest regulatory filings, with 35 funds opening new positions, 39 increasing their positions, 35 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
144
Holders Change
-1
Holders Change %
-0.69%
% of All Funds
2.09%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
35
Increased
39
Reduced
35
Closed
34
Calls
$1.26M
Puts
$110K
Net Calls
+$1.15M
Net Calls Change
-$1.96M

Top Buyers

1
BlackRock
1
BlackRock
New York
$38.5M
2
Morgan Stanley
2
Morgan Stanley
New York
$22.9M
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$12M
4
State Street
4
State Street
Massachusetts
$7.68M
5
Vanguard Group
5
Vanguard Group
Pennsylvania
$28.3M

Top Sellers

1
ICM
1
Indaba Capital Management
California
$0
2
Millennium Management
2
Millennium Management
New York
$11M
3
Balyasny Asset Management
3
Balyasny Asset Management
Illinois
$1.77M
4
Goldman Sachs
4
Goldman Sachs
New York
$1.13M
5
PHP
5
Parkman Healthcare Partners
Connecticut
$0
Name Holding Trade Value Shares
Change 		Shares
Change %
TC
176
TwinBeech Capital
New York
– -$33.8K -12,480 Closed
WAM
177
Wolverine Asset Management
Illinois
– -$271 -100 Closed
AWM
178
Avior Wealth Management
Nebraska
– -$84 -31 Closed
4 5 6 7
8